⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cd8

Every month we try and update this database with for cd8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.NCT03968419
Non-small Cell ...
Canakinumab
Pembrolizumab
18 Years - Novartis
Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis CareNCT04486820
Chordoma
Analysis Immuno...
- Centre Hospitalier Universitaire de Saint Etienne
Prognostic Biomarkers in Patients With Urothelial CarcinomaNCT04872036
Bladder Cancer
18 Years - Hellenic Cooperative Oncology Group
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursNCT05397171
Urinary Bladder...
Colorectal Canc...
Carcinoma, Non-...
AZD8853
Zirconium-89 cr...
18 Years - 130 YearsAstraZeneca
Prognostic Biomarkers in Patients With Urothelial CarcinomaNCT04872036
Bladder Cancer
18 Years - Hellenic Cooperative Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: